Log in to save to my catalogue

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell lin...

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell lin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1530321423

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line

About this item

Full title

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line

Publisher

Greece: D.A. Spandidos

Journal title

Oncology reports, 2014-07, Vol.32 (1), p.159-166

Language

English

Formats

Publication information

Publisher

Greece: D.A. Spandidos

More information

Scope and Contents

Contents

The frequent recurrence of glioblastoma multiforme (GBM) after standard treatment with temozolomide (TMZ) is a crucial issue to be solved in the clinical field. O6-methylguanine-DNA methyltransferase (MGMT) is considered one of the major mechanisms involved in TMZ resistance. However, some important mechanisms for TMZ resistance other than MGMT hav...

Alternative Titles

Full title

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1530321423

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1530321423

Other Identifiers

ISSN

1021-335X

E-ISSN

1791-2431

DOI

10.3892/or.2014.3195

How to access this item